"Designing Growth Strategies is in our DNA"

HIV Drugs Market Size, Share & Industry Analysis, By Product Type (Integrase Inhibitors, Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Combination HIV Medicines, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101115

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of HIV/AIDS, By Key Countries/Regions, 2023
    2. Regulatory Scenario by Key Countries/Regions
    3. Pipeline Analysis, By Key Players
    4. Overview of Current Advances in R&D for HIV Drugs
    5. Key Industry Developments – Mergers, Acquisitions, Partnerships etc.
    6. New Product Launches, By Key Players
    7. Impact of COVID-19 on the Market
  5. Global HIV Drugs Market Analysis, Insights and Forecast, 2019-2032 
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Integrase Inhibitors  
      2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      3. Combination HIV Medicines
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America HIV Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Integrase Inhibitors  
      2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      3. Combination HIV Medicines
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Product Type
      2. Canada
        1. By Product Type
  7. Europe HIV Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Integrase Inhibitors  
      2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      3. Combination HIV Medicines
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Germany
        1. By Product Type
      2. France
        1. By Product Type
      3. U.K.
        1. By Product Type
      4. Italy
        1. By Product Type
      5. Spain
        1. By Product Type
      6. Netherlands
        1. By Product Type
      7. Rest of Europe
        1. By Product Type
  8. Asia Pacific HIV Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Integrase Inhibitors  
      2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      3. Combination HIV Medicines
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
        1. By Product Type
      2. Japan
        1. By Product Type
      3. India
        1. By Product Type
      4. Australia
        1. By Product Type
      5. Southeast Asia
        1. By Product Type
      6. Rest of Asia Pacific
        1. By Product Type
  9. Rest of the World HIV Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Integrase Inhibitors  
      2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      3. Combination HIV Medicines
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. ViiV Healthcare
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Gilead Sciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Merck & Co., Inc.,
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Bristol-Myers Squibb Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Boehringer Ingelheim International GmbH
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. AbbVie Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. F. Hoffmann-La Roche AG (Genentech, Inc.)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Mylan N.V.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global HIV Drugs Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global HIV Drugs Market Value Share (%), By Product Type, 2023 & 2032

Figure 3: Global HIV Drugs Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 4: Global HIV Drugs Market Value (USD billion), by Region, 2023 & 2032

Figure 5: North America HIV Drugs Market Value (USD billion), By Product Type, 2023 & 2032

Figure 6: North America HIV Drugs Market Value Share (%), By Product Type, 2023

Figure 7: North America HIV Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 8: North America HIV Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 9: North America HIV Drugs Market Value (USD billion), By Country, 2023 & 2032

Figure 10: North America HIV Drugs Market Value Share (%), By Country, 2023

Figure 11: Europe HIV Drugs Market Value (USD billion), By Product Type, 2023 & 2032

Figure 12: Europe HIV Drugs Market Value Share (%), By Product Type, 2023

Figure 13: Europe HIV Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 14: Europe HIV Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 15: Europe HIV Drugs Market Value (USD billion), By Country/ Sub-Region, 2023 & 2032

Figure 16: Europe HIV Drugs Market Value Share (%), By Country/ Sub-Region, 2023

Figure 17: Asia Pacific HIV Drugs Market Value (USD billion), By Product Type, 2023 & 2032

Figure 18: Asia Pacific HIV Drugs Market Value Share (%), By Product Type, 2023

Figure 19: Asia Pacific HIV Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 20: Asia Pacific HIV Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 21: Asia Pacific HIV Drugs Market Value (USD billion), By Country/ Sub-Region, 2023 & 2032

Figure 22: Asia Pacific HIV Drugs Market Value Share (%), By Country/ Sub-Region, 2023

Figure 23: Rest of the World HIV Drugs Market Value (USD billion), By Product Type, 2023 & 2032

Figure 24: Rest of the World HIV Drugs Market Value Share (%), By Product Type, 2023

Figure 25: Rest of the World HIV Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 26: Rest of the World HIV Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 27: Global HIV Drugs Market Share (%), By Company, 2023

Table 1: Global HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 2: Global HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 3: Global HIV Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 4: North America HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019-2032

Table 5: North America HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 6: North America HIV Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 7: U.S. HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 8: Canada HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 9: Europe HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019-2032

Table 10: Europe HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 11: Europe HIV Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2032

Table 12: Germany HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 13: France HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 14: U.K. HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 15: Italy HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 16: Spain HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 17: Netherlands HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 18: Rest of Europe HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 19: Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019-2032

Table 20: Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 21: Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2032

Table 22: China HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 23: Japan HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 24: India HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 25: Australia HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 26: Southeast Asia HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 27: Rest of Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019–2032

Table 28: Rest of the World HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2019-2032

Table 29: Rest of the World HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Hiv/Aids Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 120
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase